Huo D - Search Results

1

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.

Kane S, Huo D, Aikens J, Hanauer S. Kane S, et al. Among authors: huo d. Am J Med. 2003 Jan;114(1):39-43. doi: 10.1016/s0002-9343(02)01383-9. Am J Med. 2003. PMID: 12543288

2

A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis.

Kane S, Huo D, Magnanti K. Kane S, et al. Among authors: huo d. Clin Gastroenterol Hepatol. 2003 May;1(3):170-3. doi: 10.1053/cgh.2003.50025. Clin Gastroenterol Hepatol. 2003. PMID: 15017487 Clinical Trial.

3

Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.

Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Rubin DT, et al. Among authors: huo d. Clin Gastroenterol Hepatol. 2006 Nov;4(11):1346-50. doi: 10.1016/j.cgh.2006.08.014. Epub 2006 Oct 23. Clin Gastroenterol Hepatol. 2006. PMID: 17059900

4

Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.

Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Pekow JR, et al. Among authors: huo d. Inflamm Bowel Dis. 2010 Aug;16(8):1352-6. doi: 10.1002/ibd.21184. Inflamm Bowel Dis. 2010. PMID: 20027656 Free PMC article.

5

Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Rubin DT, et al. Among authors: huo d. Clin Gastroenterol Hepatol. 2013 Dec;11(12):1601-8.e1-4. doi: 10.1016/j.cgh.2013.06.023. Epub 2013 Jul 17. Clin Gastroenterol Hepatol. 2013. PMID: 23872237 Free PMC article.

6

Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.

Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT. Krugliak Cleveland N, et al. Among authors: huo d. Gastrointest Endosc. 2018 May;87(5):1304-1309. doi: 10.1016/j.gie.2017.12.016. Epub 2018 Jan 4. Gastrointest Endosc. 2018. PMID: 29307473 Free PMC article.

7

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.

Cohen EE, Rosen F, Stadler WM, Recant W, Stenson K, Huo D, Vokes EE. Cohen EE, et al. Among authors: huo d. J Clin Oncol. 2003 May 15;21(10):1980-7. doi: 10.1200/JCO.2003.10.051. J Clin Oncol. 2003. PMID: 12743152 Clinical Trial.

8

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Schreiber MD, et al. Among authors: huo d. N Engl J Med. 2003 Nov 27;349(22):2099-107. doi: 10.1056/NEJMoa031154. N Engl J Med. 2003. PMID: 14645637 Free article. Clinical Trial.

9

Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide.

Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Mestan KK, et al. Among authors: huo d. N Engl J Med. 2005 Jul 7;353(1):23-32. doi: 10.1056/NEJMoa043514. N Engl J Med. 2005. PMID: 16000353 Free article. Clinical Trial.

10

Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Cohen EE, et al. Among authors: huo d. Clin Cancer Res. 2005 Dec 1;11(23):8418-24. doi: 10.1158/1078-0432.CCR-05-1247. Clin Cancer Res. 2005. PMID: 16322304 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

931 results

Search Page